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The cationic molecule thrombin-induced platelet microbicidal protein 1 (tPMP-1) exerts potent activity
against Staphylococcus aureus. We previously reported that a Tn551 S. aureus transposon mutant, ISP479R, and
two bacteriophage back-transductants, TxA and TxB, exhibit reduced in vitro susceptibility to tPMP-1 (tPMP-
1r) compared to the parental strain, ISP479C (V. Dhawan, M. R. Yeaman, A. L. Cheung, E. Kim, P. M. Sullam,
and A. S. Bayer, Infect. Immun. 65:3293–3299, 1997). In the current study, the genetic basis for tPMP-1r in
these mutants was identified. GenBank homology searches using sequence corresponding to chromosomal
DNA flanking Tn551 mutant strains showed that the fourth gene in the staphylococcal mnh operon
(mnhABCDEFG) was insertionally inactivated. This operon was previously reported to encode a Na/H
antiporter involved in pH tolerance and halotolerance. However, the capacity of ISP479R to grow at pH
extremes and in high NaCl concentrations (1 to 3 M), coupled with its loss of transmembrane potential ()
during postexponential growth, suggested that the mnh gene products are not functioning as a secondary (i.e.,
passive) Na/H antiporter. Moreover, we identified protein homologies between mnhD and the nuo genes of
Escherichia coli that encode components of a complex I NADH:ubiquinone oxidoreductase. Consistent with
these data, exposures of tPMP-1-susceptible (tPMP-1s) parental strains (both clinical and laboratory derived)
with either CCCP (a proton ionophore which collapses the proton motive force) or pieracidin A (a specific
complex I enzyme inhibitor) significantly reduced tPMP-induced killing to levels seen in the tPMP-1r mutants.
To reflect the energization of the gene products encoded by the mnh operon, we have renamed the locus sno (S.
aureus nuo orthologue). These novel findings indicate that disruption of a complex I enzyme locus can confer
reduced in vitro susceptibility to tPMP-1 in S. aureus.
Over the past decade, it has become increasingly clear that
mammalian platelets play a critical role in innate host defense
against the induction and progression of endovascular infec-
tions (9, 10, 25, 26, 47). This host defense property relates to
the capacity of platelets to release a group of cationic antimi-
crobial peptides collectively known as platelet microbicidal
proteins (PMPs) at sites of endovascular damage or infection
(9, 19, 25, 26). Both rabbit and human platelets release func-
tionally and structurally similar PMPs (43, 50). These peptides
have potent microbiostatic and microbicidal activities in vitro
against pathogens that commonly invade the bloodstream (i.e.,
Staphylococcus aureus, coagulase-negative staphylococci, viri-
dans group streptococci, and Candida species) (44). Several
PMPs contain functionally conserved structural themes: a C-
terminal -helical microbicidal domain and an N-terminal che-
mokine domain, linked by an interposing -core motif that is
reiterated in diverse microbicidal chemokines (kinocidins) and
classical cysteine-stabilized antimicrobial peptides (51, 52).
To date, the most extensively characterized PMPs are those
released from platelets following stimulation by the procoagu-
lant molecule thrombin (i.e., thrombin-induced PMPs
[tPMPs]) (9, 10, 25, 43, 44, 50, 51). In humans with S. aureus
bacteremia, we have previously shown that strains which are
intrinsically susceptible to tPMPs (tPMPs) in vitro are less
likely to cause complicated endovascular infections, such as
endocarditis. In addition, such strains are more rapidly cleared
from the bloodstream than strains exhibiting in vitro the tPMPr
phenotype (12, 13). Similarly, S. aureus isolates from the nares
of healthy humans are more susceptible to killing by tPMPs in
vitro than strains from either the nares or bloodstream of
hemodialysis patients, a population of bacteria experiencing
extensive blood contact (V. G. Fowler, L. M. McIntyre, C. H.
Cabell, L. B. Reller, G. R. Corey, T. Jones, K. Clark, M. R.
Yeaman, and A. S. Bayer, Abstr. 103rd Gen. Meet. Am. Soc.
Microbiol., abstr. E-004, p. 250, 2003).
Recent studies indicate that tPMPs target and permeabilize
the S. aureus cytoplasmic membrane (CM), initiating the en-
suing lethal mechanisms of these peptides. Intracellular targets
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affecting macromolecular synthesis and autolytic enzyme path-
ways have also been implicated in the staphylocidal mecha-
nisms of tPMPs (45, 46, 48). The precise countermeasures by
which S. aureus strains may resist the microbicidal activity of
tPMPs remain incompletely defined but appear to include en-
hanced membrane fluidity (5), reduced transmembrane poten-
tial () (21), and carriage of plasmids encoding transmem-
brane efflux pumps for cationic compounds (26).
We previously reported on a tPMPr S. aureus strain,
ISP479R, a Tn551 transposon mutant of the tPMPs parental
strain, ISP479C (10). A number of subsequent investigations in
a model of experimental endocarditis have shown that, com-
pared to its isogenic parental strain, ISP479R is cleared more
slowly and to a lesser extent from target tissues, both during
the natural history of the infection as well as during antimi-
crobial prophylaxis and therapy (9, 10, 25). The current study
was designed to identify the genetic determinants correspond-
ing to the site of the Tn551 insertion in strain ISP479R and
correlate transposon disruption of this site with specific phe-
notypes that may contribute to reduced in vitro killing by
tPMPs.
(This work was presented in part at the 103rd General Meet-
ing of the American Society for Microbiology, May 2003,
Washington, D.C., and at the 8th International Society for
Cardiovascular Infectious Diseases Congress, October 2005,
Charleston, S.C.).
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains used
in this study are listed in Table 1. S. aureus parental strain ISP479 (tPMP-1s)
harbors plasmid pI258, which has a temperature-sensitive replicon and carries
transposon Tn551, which confers erythromycin resistance. ISP479C is a well-
characterized tPMP-1s S. aureus strain that is a spontaneously cured, plasmid-
and transposon-free variant of ISP479 (10). We have previously detailed the
construction of ISP479R by transposition of Tn551 (10). Strains ISP479C and
ISP479R are virtually identical in the following phenotypic and genotypic pa-
rameters: colonial pigmentation, hemolytic characteristics, coagulase, DNase,
pulsed-field gel electrophoretograms, biotyping, antibiograms, platelet adher-
ence and aggregation capacities, growth kinetics, cell wall-associated protein A
expression, and fibrinogen-binding capacity (10). Moreover, growth of ISP479R
on Mueller-Hinton (MH) agar revealed no evidence of small colony variant
formation. The broth macrodilution MICs for ISP479C and ISP479R of genta-
micin were 0.25 and 0.5 g ml1 at final inocula of 5  105 and 5  106 CFU
(cation-supplemented MH broth) (unpublished data).
We have also previously described the construction of two tPMPr transduc-
tants of ISP479R into the tPMPs parental strain, ISP479C, named TxA and TxB
(3). ISP479 is of a genetic lineage related to S. aureus strain 8325-4, which
contains a natural 11-bp deletion within the rsbU locus of the stress response
operon, sigB (18). This deletion renders such strains partially sigB deficient in
terms of stress responses (36). Since exposure of bacteria to cytoplasmic mem-
brane-permeabilizing tPMPs is undoubtedly a substantial stress, perturbations in
sigB function may potentially impact survival outcomes following peptide expo-
TABLE 1. Plasmids and bacterial strains
Strain or plasmid Genotype, phenotype, and/or description Reference or source
E. coli DH5 F 	80lacZM15 (lacZYA-argF)U169 endA1 recA1 hsdR17(rK
 mK
) deoR thi-1
supE44 
 gyrA96 relA1
BRL
S. aureus strains
6850 Clinical isolate 20
ISP479 pI258 Cadr, Penr Ars/Asir Tn511[ermC] 37
ISP479C ISP479 cured of pI258, tPMP-1s 10
ISP479R ISP479 snoD::Tn511[ermC] 10
ISP479R-complemented ISP479R geh::pJM7989 (snoA-G), tPMP-1s This study
ISP479R(pJM282) ISP479R with pJM282 This study
RN4220 8325-4, nitrosoguanidine-induced restriction mutant used as primary recipient for
plasmids propagated in E. coli
35
SH1000 8325-4 rsbU positive, tPMP-1s 16
SH1000-98 snoD::Tn551, tPMP-1r This study
TxA 	11/ISP479R  ISP479C,a tPMP-1r, snoD::Tn511[ermC] This study
TxA complemented TxA geh::pJM798 (snoA-G), tPMP-1s This study
TxB 	11/ISP479R  ISP479C, tPMP-1r, snoD::Tn551 This study
TxB-1 compemented TxB geh::pJM798 (snoA-G), tPMP-1s This study
Plasmids
pCL55 S. aureus integration-shuttle vector 27
pCRII t-tail cloning vector Invitogen Life
Technologies,
Carlsbad, CA
pIM36 pBlueScript II KS()::tnp(Tn551) 32
pIM40 pT7Blue::geh 32
pJM272 pRN6680 with blaZ deleted This study
pJM282 pJM272 with a 1.85-kb EcoRI-ClaI fragment from pCL55 with 	L54a int and
attP, serves as a site-specific chromosomal integration vector for S. aureus
This study
pJM795 pCRII with snoA-G flanked by NotI sites amplified from plasmid pNAS20 This study
pJM798 pJM272::snoA-G This study
pNAS20 pUC19 with mnhA-G (snoA-G)
pRN6680 pBluescript SKII() with a 2.9-kb DNA fragment with tetM 34
pT7Blue t-tail cloning vector Novagen, Madison,
Wis.
a Phage/host  recipient.
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sure. With this in mind, selected phenotypic and genotypic studies (detailed
below) were performed in parallel with both ISP479-derived constructs as well as
with transductants created using a rsbU-repaired variant (in which SigB activity
is therefore restored to wild type) of ISP479 lineage, SH1000 (see construction
details below) (16). As with tPMP-1r strains derived from ISP479C, SH1000
tPMP-1r derivatives grew as well as SH1000 in vitro.
In addition to the laboratory-derived strains described above, select studies
included the clinical isolate S. aureus strain 6850. Strain 6850 was isolated from
a patient with bacteremia, osteomyelitis, and soft tissue abscesses. This strain
(which is tPMP-1s) has been used in our laboratories in studies of antimicrobial
peptides and transmembrane potential in S. aureus (20). This strain was princi-
pally used in the proton motive force (PMF) inhibitor investigations (see below).
For routine growth, S. aureus strains were cultivated in either brain heart
infusion (BHI) broth (Difco, Detroit, MI) or tryptic soy broth (Difco Laborato-
ries, Detroit, MI) with rotary agitation (250 rpm) or on medium augmented with
1.5% agar at 37°C. Escherichia coli strains were grown in Luria-Bertani (LB)
broth with rotary agitation or on LB agar plates incubated at 37°C. For S. aureus,
tetracycline and erythromycin selection used medium supplemented with anti-
biotic at a concentration of 10 g and 5 g ml1, respectively. Resistant E. coli
was grown in medium containing 100 g ml1 ampicillin or 12.5 g ml1
tetracycline. All strains were stored at 70°C.
Genotypic studies: genetic linkage analysis and construction of tPMP-1r vari-
ants in SH1000. To confirm a genetic linkage between Tn551 in ISP479R and the
in vitro tPMPr phenotype, cotransduction studies were performed as previously
described using phage 	11 lysates from strain ISP479R (11). Generalized trans-
duction of the rsbU-repaired, tPMPs parental strain, SH1000, was performed at
a multiplicity of infection of a 1:10 ratio of bacteriophage to recipient cells.
Transductants were selected on 0.3% glycerol-lactate agar containing erythro-
mycin, and tPMPr candidates were initially identified by resistance to the cationic
antimicrobial peptide protamine (used in a number of previous studies as a
screening surrogate antimicrobial peptide in place of tPMPs [10]). Candidate
transductants were then checked for a stable tPMPr phenotype using a standard
microtiter killing assay as previously described (5, 44). S. aureus transductant
SH1000-98 was identified by this protocol and used in the subsequent studies
described below.
Southern hybridization. We have previously shown that ISP479C is Tn551
free, while in strains ISP479R and TxB, the transposon resides within similarly
sized restriction endonuclease fragments (10). To verify the genotype of the
strains used in this study and to provide additional information on the size of the
Tn551-containing DNA fragment for estimating the appropriate amplification
times for inverse PCR, we probed the chromosome of the strains used in this
study for Tn551 by Southern hybridization.
Briefly, staphylococcal chromosomal DNA was isolated (11) and subjected to
electrophoresis through 0.7% agarose gels. DNA was transferred to nylon mem-
branes (MagnaGraph; Fisher Scientific, Pittsburgh, PA) and probed using either
digoxigenin- or [-32P]dCTP-labeled probes (as noted in the figure legends). The
probes used for Southern analysis included a1.2-kb HindIII fragment encoding
the Tn551 transposase from plasmid pIM36 and a 2.7-kb BamHI-HindIII
fragment encoding the gene for glycerol ester hydrolase (geh) from plasmid
pIM40. Digoxigenin-labeled probes were prepared as described for use with the
Genius system (Boehringer Mannheim, Indianapolis, IN). Prehybridization and
hybridization used standard buffer plus 50% formamide according to the man-
ufacturer’s instructions. Chemiluminescent probe detection used the substrate
disodium 3-(4-methoxyspiro{1,2-dioxetane-3,2-(5-chloro)tricyclo[3.3.2.237]decan}-
4-yl)phenyl phosphate (Boehringer Mannheim). Radiolabeled probes were pre-
pared using the Prime-a-Gene labeling kit (Promega, Madison, WI) according to
the manufacturer’s instructions. Prehybridization and hybridization used 1 SSC
(0.15 M NaCl and 0.015 M sodium citrate), 1% sodium dodecyl sulfate (SDS),
0.5% formamide, Denhardt’s solution (0.04% Ficoll 400, 0.04% polyvinylpyrro-
lidone, and 0.04% bovine serum albumin, fraction V), and 2.5 mg ml1 yeast
RNA. All membranes were prehybridized for 4 h and hybridized for 12 h at 42°C,
washed twice with 2 SSC containing 0.1% SDS for 5 and 15 min at room
temperature, and washed once each in 0.5 SSC, 0.1% SDS for 15 min, 0.1
SSC, 0.1% SDS for 15 min, and 0.1 SSC, 1.0% SDS for 30 min. The later
washes were performed at 68°C. Probes were detected by exposure of Kodak
X-Omat AR film.
Identification of the transposon insertion site in tPMPr strains. To identify
the Tn551-disrupted gene in tPMPr strains ISP479R, TxB, and SH1000-98, DNA
flanking the site of the transposon insertion site was amplified by inverse PCR
and sequenced, with the sequence of the amplified product then used to search
GenBank. Chromosomal DNA isolated from the mutant strains was prepared by
digestion with PstI. The digested DNA was self-ligated, purified by phenol
extraction, concentrated by ethanol precipitation, and used as the template for
PCR. PCRs consisted of 0.5 g DNA, 1 U high-fidelity polymerase mix (Boehr-
inger Mannheim, Indianapolis, IN), 200 M nucleotides, and 1.0 M primers in
each of seven 100-l reaction mixtures that contained a range of 0.0 to 8.5 mM
MgCl2 (8). Primers were designed to extend outward from the 5 and 3 ends of
Tn551 (GenBank accession no. Y13600): 5-GCGGCCGCTCATTAATGACA
CGGTGGAATG and 5-5GCGGCCGCGTTTCGTGTCGGGTCAATGATTG,
respectively.
Amplified products were analyzed by agarose gel electrophoresis and by nu-
cleotide sequence determination. Sequence data were obtained using an Applied
Biosystems 377 DNA sequencer with dye terminator cycle sequencing chemistry
(Perkin-Elmer, Foster City, CA) on a QIAquick PCR purification kit (QIAGEN,
Chatsworth, CA), with purified templates initially using the Tn551 primers and,
later, primers designed to the determined sequence. Sequence was compiled and
analyzed using Sequencher version 4.1 (Gene Codes, Ann Arbor, MI) and Blastx
(1), respectively.
Second-site complementation. As noted in the Results section below, the
transposon disruption mapped to the mnh operon (mnhABCDEFG) of S. aureus
(15). For complementation studies, the wild-type mnh operon (from plasmid
pNAS20; kindly provided by T. Hiramatsu, Tsushima, Okayama, Japan) was
integrated into the chromosomal gene encoding lipase in S. aureus strains
ISP479R, TxA, and TxB, using well-established techniques (27). The integration
vector, pJM798, was constructed from plasmid pRN6680. Plasmid pRN668 is the
cloning vector pBluescript (Stratagene, La Jolla, CA) with a 2.9-kb DNA frag-
ment encoding a staphylococcal tetracycline resistance marker, tetM (25). The
gene encoding -lactamase was deleted from pRN6680 by BglI digestion fol-
lowed by intermolecular ligation creating pJM272. A 1.85-kb EcoRI-ClaI frag-
ment from plasmid pCL55 (27), containing the L54a att site, and integrase was
cloned into the similar site in pJM272, creating plasmid pJM282. The mnh
operon was amplified from plasmid pNAS20 t-tail cloned into pCRII, creating
pJM795 (15). The mnh-specific primers with 5-appended NotI sites were 5-G
CGGCCGCTCATTAATGACACGGTGGAATG and 5-GCGGCCGCGTTT
CGTGTGGGTCAATGATTG. Plasmid pJM795 was digested with NotI, and
the mnh-containing fragment was transferred into a similar site within pJM282,
creating plasmid pJM798 (see Fig. 5, below). Plasmid pJM798 was introduced
into S. aureus strain RN4220 by electroporation and then transduced to
ISP479R, TxA, and TxB using bacteriophage 	11, selecting for pJM798-encoded
tetracycline resistance using previously described procedures (2, 32). Correct
chromosomal insertion was verified by Southern analysis.
As a control for the impact of lipase locus disruption on tPMP-1 susceptibility
phenotypes, we constructed strain ISP479R(pJM282), which is ISP479R carrying
a chromosomal integration of pJM282 (without mnhABCDEFG). The integra-
tion vector was introduced into ISP479R by transduction of tetracycline resis-
tance encoded on a chromosomal copy of pJM282 in PM291.
Phenotypic studies: preparation of tPMP-1. For this study, we focused on
tPMP-1 since it is the most abundant of the tPMPs in rabbit platelets (a standard
in vivo model of S. aureus endovascular pathogenesis [25, 50]). Supernatants
from thrombin-stimulated rabbit platelets were prepared as previously described
(50). Purification of tPMP-1 was achieved by column chromatography followed
by reversed-phase high-performance liquid chromatography. Bioactivity of
tPMP-1 preparations was validated as previously published (43, 50). Purified and
bioactive tPMP-1 was lyophilized and kept frozen at 20°C until thawed for use.
Standard tPMP-1 susceptibility assay. Susceptibility profiles of the study con-
structs to tPMP-1 were determined by timed-kill assay as described elsewhere
(44). Overnight cultures of the S. aureus isolates were washed twice and sus-
pended in phosphate-buffered saline. Dilutions of tPMP-1 and S. aureus isolates
were added to polypropylene microculture tubes containing Eagle’s minimal
essential medium (Irvine Scientific, Santa Ana, CA) to achieve a final tPMP-1
concentration of 1 or 2 g ml1 and a final bacterial inoculum of 103 CFU ml1
(e.g., the standard inoculum and peptide concentration used for tests of this
peptide against S. aureus strains [43]). For determinations of percent survival,
one tube contained only bacteria and minimal essential medium and acted as a
positive growth control. After 2 h of incubation at 37°C, suspensions were mixed
by vortexing, and 15-l aliquots were removed from each tube and quantitatively
cultured onto blood agar plates. The proportion of S. aureus cells of each
construct surviving a 2-h exposure to tPMP-1 was expressed as the percent CFU
of the positive growth control. All assays were performed in triplicate on two
separate days, and the mean percent survival  the standard deviation (SD) was
determined. A tPMP-1r phenotype was defined as 50% survival of the initial
inoculum after a 2-h exposure to 1 or 2 g ml1 tPMP-1 at 37°C. This arbitrary
in vitro breakpoint correlates with an enhanced capacity of such strains in vivo to
induce and propagate human or experimental infective endocarditis (12, 25, 44).
Standard protamine susceptibility assay. All study strains were also tested for
their MICs to protamine by an agar dilution assay. As noted above, protamine is
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a cationic antimicrobial peptide from salmon sperm whose in vitro activity
against S. aureus tends to closely parallel that of tPMP-1 (9, 10). Prior studies
have shown the MICs of strains ISP479C and ISP479R to be 1 to 2 versus 8 mg
ml1, respectively (10). Briefly, protamine sulfate (Sigma Chemical, St. Louis,
MO) was incorporated into LB agar plates over a range of concentrations from
1 to 16 mg ml1. After inoculating 5  107 CFU onto their surface, the plates
were incubated for 48 h at 37°C. The MIC was determined as the lowest prota-
mine concentration inhibiting all visible growth.
Membrane fluidity assays. Increased membrane fluidity has been a consistent
feature of most tPMP-1r S. aureus isolates analyzed to date (5). Thus, we assessed
this parameter in our study strains by quantifying the relative distribution and
two-dimensional orientation of a fluorescent dye within the lipid layers of the
cytoplasmic membrane. In brief, a whole-cell suspension of each bacterial strain
was prepared with a bacterial density of109 CFU ml1. Cells were then labeled
with a fluorescent dye, 1,6-diphenyl-1,3,5-hexatriane (DPH; Sigma Chemical, St.
Louis, MO) (5). DPH specifically labels and fluoresces within the hydrophobic
regions of the lipid bilayer but lacks fluorescence in aqueous environments (5).
The steady-state fluorescence of the DPH probe predominantly reflects the
structural order of membrane lipids, as a result of partitioning of the probe into
the hydrocarbon phase of the lipid membrane bilayer when it is in a fluid state.
Thus, membrane fluidity may be considered as the reciprocal of the structured
order of membrane lipids. For DPH labeling, a 2 mM solution of this dye was
prepared in tetrahydrofuran, and 100 l was added to 50 ml of agitated 0.05 M
Tris-HCl (pH 7.6). Excess tetrahydrofuran was removed by flushing with nitro-
gen. Cells were then incubated in DPH at a final concentration of 2 M for 3 h
at 30°C.
Fluorescence polarization was measured using a Kontron spectrofluorometer
(Copenhagen, Denmark) as previously detailed (5). Excitation of the fluorescent
probe was accomplished with vertically polarized monochromatic light at 360 nm
for DPH, with emission intensity quantified at 426 nm, using a detector oriented
either parallel to or perpendicular to the direction of the polarized excitation
source. The degree of fluorescence polarization or polarization index (PI) was
calculated as described previously (5). The lower the PI value, the more fluid the
membrane.
Membrane potential () assays. For the determination of , 1 Ci of
radiolabeled tetraphenylphosphoniumbromide ([3H]TPP; Amersham, Piscat-
away, NJ) corresponding to 0.04 nM TPP was added to 1-ml culture aliquots of
108 CFU of bacteria. This lipophilic cation diffuses across the bacterial mem-
brane in response to the membrane potential, with the negative pole being inside
the cells. Cells were grown in chemically defined medium as previously reported
(4, 42) at 37°C with agitation, and aliquots were removed serially over a 6-h
period for determination of the optical density at 600 nm (OD600) and for 
measurements. For the latter analyses, samples of 100 l were filtered on cellu-
lose acetate filters (pore size, 0.2 m; Schleicher & Schuell, Keene, NH) and
washed twice with 5 ml 50 mM potassium phosphate buffer. Filters were dried,
transferred to counting vials filled with scintillation fluid (Quickzint 100; Zinsser
Analytic, Frankfurt, Germany), and counted in a Packard liquid scintillation
analyzer (Tri-Carb 1900 CA). Counts were corrected for nonspecific binding of
TPP to bacterial cells by subtracting the radioactivity retained by cells after
treatment with 10% butanol. The membrane potential was calculated by means
of the Nernst equation,   (2.3  R  T/F)  log([TPPin]/[TPPout]), with
R being the universal gas constant, T the absolute temperature in Kelvin, F the
Faraday’s constant, [TPPin] the molar concentration of TPP inside the bac-
terial cells, and [TPPout] the molar concentration of TPP in the medium. The
internal volume of 3.4 l mg1 protein of staphylococcal cells used for calcula-
tion of [TPPin] was determined previously (4, 42).
Staphylococcal growth in hypertonic saline and at various pHs. Halotolerance
of the study strains was tested using standard BHI broth or BHI broth supple-
mented with NaCl at a final concentration range of 50 mM to 3 M (pH 7.2), with
a starting inoculum of 104 CFU ml1 of bacteria. In parallel, pH tolerance was
determined using similarly inoculated BHI broth, adjusted with either HCl or
NaOH to provide a final pH range from 4.5 to 8.5. All cultures were incubated
at 37°C with rotary agitation. For halotolerance, the OD600 was measured in
culture aliquots obtained at even-hour intervals for 10 h. For pH tolerance,
OD600 measurements and comparisons were made on samples obtained at 8 h
(41).
PMF and complex 1 inhibitor studies. To decrease the PMF, we used carbon-
ylcyanide m-chlorophenylhydrazone (CCCP; Sigma Chemical), an uncoupler of
oxidative phosphorylation. Test strain ISP479C and the clinical isolate 6850 were
grown to stationary phase at 37°C in MH broth, because this medium contains
very little glucose compared to brain heart infusion broth (high glucose concen-
trations reverse the effects of CCCP [33]). Cells were harvested, washed twice in
buffered saline, added to fresh MH broth, and grown for 30 min at 37°C in the
presence or absence of 100 M CCCP. Cells were then harvested and processed
through the standard tPMP-1 susceptibility assay described above, using a final
peptide concentration range of 0.25 to 2 g1. Piericidin A is a specific inhibitor
of complex I NADH oxidoreductases (6). For piericidin A studies, the same
protocol as used for CCCP was followed, only substituting piericidin A (4.0 or 8.0
M) for CCCP.
Statistical analysis. Continuous data were analyzed by the Kruskal Wallis
analysis of variance, with the Tukey post hoc correction for multiple comparisons
where appropriate. A P value of 0.05 was considered significant.
RESULTS
Southern analysis of isogenic constructs. The Tn551 probe
detected a single DNA fragment in ISP479R that was not in
the parental strain (Fig. 1). Chromosomal DNA from ISP479R
digested with EcoRI resulted in identification of a 13-kb frag-
ment, while the probe hybridized with a 10.2-kb PstI-digested
DNA fragment. These insert sites are identical to those previ-
ously identified and reported (10). Also, as previously re-
ported, Southern analyses confirmed the presence of a single
Tn551 insert in the tPMP-1r transductant constructs, TxA and
TxB (data not shown) (10). Within the tPMP-1r strain SH1000-
98, Tn551 resided on restriction fragments identical in size to
those associated with ISP479R (Fig. 2).
Identification of the transposon insertion site. Inverse PCR
using Tn551-derived primers on PstI-digested chromosomal
DNA from strains ISP479R, TxA, TxB, and SH1000-98 ampli-
fied a single product. The concentration of MgCl2 used in the
amplification reaction mixtures affected formation of the prod-
uct. For each strain, no specific DNA amplification was ob-
served when less than 3.0 mM MgCl2 was used in the reaction
mixture, while concentrations of MgCl2 that ranged from 3.0 to
9.0 mM resulted in amplification of a 5-kb DNA fragment (Fig.
3, ISP479R). The size of this fragment is consistent with the
Southern hybridization data. The 10.2-kb PstI-hybridizing frag-
FIG. 1. Southern analysis of DNA isolated from the tPMP-1r trans-
poson mutant ISP479R (lanes 1 and 3) and parental tPMP-1s, ISP479C
(lanes 2 and 4), probed with a transposon-specific probe. Chromo-
somal DNA was digested with EcoRI (lanes 1 and 2) or PstI (lanes 3
and 4). A probe that hybridizes with the gene encoding the transposase
of Tn551 detected a single 13-kb EcoRI fragment and a 10.2-kb PstI
fragment in strain ISP479R that was not in parent strain ISP479C.
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ment corresponds to the size of the amplified product plus the
5.2 kb of DNA comprising Tn551.
Nucleotide sequences of 540 bp and 65 bp were directly
determined from the PCR products, which corresponded to
DNA flanking the 5 and 3 ends of the transposon, respec-
tively. Using these data as the query sequence in Blastx
searches of published S. aureus genomes, we found that the
transposon had inserted into the gene previously identified as
mnhD. The mnhD locus encodes a putative subunit of a
Na/H antiporter encoded by mnhABCDEFG (15). The
quality of the data generated by sequencing the sense and
antisense DNA from the above tPMP-1r constructs allowed for
accurate mapping of the transposon insertion site to within a
65-bp segment of chromosome and for determination of the
orientation of the transposon relative to the disrupted gene
(Fig. 4).
Sequence searches in GenBank revealed that, in addition to
a putative Na/H antiporter, the gene containing the trans-
poson insertion site encodes a protein with homology to mem-
bers of the NADH-ubiquinone/plastoquinone (complex I) en-
zyme family (pfam 0036; expectation 6e22). Included in this
protein family are the E. coli complex I-coding subunits en-
coded by nuoL, nuoM, and nuoN (expectation  7e21, 1e26,
and 5e24, respectively) (29). GenBank searches also identified
similar proteins in a variety of organisms. Outside of the da-
tabase entries for staphylococcal species, the gene with the
highest homology to the wild-type allele of the disrupted gene
was mpr (expectation  e110), a Bacillus subtilis complex
I-like-encoding operon that reportedly confers Na and
cholate resistance and maintains pH homeostasis (17).
Based on the above genotypic analyses and the phenotypic
studies detailed below, we renamed the disrupted operon sno-
ABCDEFG (snoA-G, for staphylococcal nuo-like orthologues
A through G). This nomenclature will be used for the remain-
der of the paper.
Second-site complementation of snoD. It is conceivable that
snoD may be the only gene within the snoA-G operon whose
function is adversely affected by the Tn551 mutation. However,
it is also possible that, depending on transcriptional content
and translational start and stop sequences of the sno messages,
additional genes upstream or downstream of snoD within the
operon may have altered expression. Given this possibility, we
utilized the entire seven-gene sno operon for second-site
complementation studies.
A wild-type copy of the operon, carried on plasmid pJM798
(Fig. 5), was integrated into the chromosomal gene encoding
glycerol ester hydrolase (lipase gene, geh) in S. aureus strains
ISP479R and TxB. Interruption of the chromosomal copy of
this gene by integration of plasmid pJM798 was examined by
Southern analysis in strains ISP479R, ISP479R with pJM798,
TxB, and TxB with pJM798 (Fig. 6). The lipase gene resides
within an 8-kb fragment in strains without pJM798 integrated
into the chromosome. Upon plasmid integration into the lipase
FIG. 2. Southern analysis of S. aureus SH1000-98, a PMP-1r trans-
ductant derived from ISP479R. Lanes 1 and 2 contain chromosomal
DNA from ISP479R, lanes 3 and 4 contain chromosomal DNA from
strain SH1000, and lanes 5 and 6 contain DNA from SH1000-98. The
even-numbered lanes contain PstI-digested DNA, while the odd-num-
bered lanes contain EcoRI-digested DNA. A Tn551-specific probe
detected similarly sized DNA fragments in ISP479R and SH1000-98
that were not present in SH1000 or ISP479C (Fig. 1).
FIG. 3. Amplification of the Tn551 insert site in strain ISP479R. A
0.75% agarose gel with the 1-kb ladder (lane 1) and five independent
inverse PCRs that used a PstI-generated template and MgCl2 concen-
trations ranging from 0.0 to 9 mM in 1.5 mM increments (lanes 2 to 5).
An arrow marks a 5-kb product. The size of this fragment is consistent
with the Southern blot data (Fig. 1); the 10.2-kb PstI fragment corre-
sponds to the size of the amplified product plus the 5.2 kb of DNA
comprising Tn551. Similar DNA band patterns were observed for TxA,
TxB, and SH1000-98 (data not shown).
FIG. 4. Map of the Tn551 insertion site in strains ISP479R, TxA,
TxB, and SH1000-98. The sno (mnh) operon is shown and consists of
six genes (rectangles labeled A through G). Tn551 is depicted by the
rectangle above the map of the sno (mnh) operon. The arrows within
the depicted genes indicate the orientation of transcription of snoA-G
(mnhA-G) and Tn551. The converging lines from the ends of the
representation of Tn551 show the approximate location of the trans-
poson insertion site.
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gene, an EcoRV site within pJM798 results in two fragments.
The sizes of the two fragments correspond to the sum of the
geh EcoRV fragment in the wild-type strain plus the 13 kb of
pJM798. These studies confirmed the successful integration of
pJM798 into the targeted chromosomal locus in the tPMP-1r
constructs.
Antimicrobial peptide susceptibility profiles. As shown in
Table 2, compared to their parental strain (ISP479C), the
original Tn551 mutant (strain ISP479R) and transductants de-
rived from ISP479R (strains TxA and TxB) exhibited reduced
susceptibility to tPMP-1 and protamine. With regard to strains
with the ISP479C genetic background, these data are consis-
tent with our previously reported results (10). Of note, the
reduced susceptibility to tPMP-1 for the transductant strains
was virtually identical to the original transposon mutant
(ISP479R). S. aureus strain SH1000-98, a transductant derived
from ISP479R that carries the defined Tn551 mutation, exhib-
ited reduced susceptibility to tPMP-1 compared to its parent
strain, SH1000. Second-site complementation with a wild-type
copy of the sno operon in the original transposon mutant, as
well as both TxA and TxB, restored a tPMP-1s phenotype,
although the susceptibility profile did not fully reach parental
levels. The ISP479R-derived strain in which the lipase gene
was disrupted by the plasmid vector alone (without the snoA-G
complementation) remained tPMP-1r.
All tPMP-1r strains also exhibited an eightfold increase in
their MICs of a second cationic bactericidal peptide, prota-
mine, compared to their respective parental strains. Of note,
second-site complementation of all the tPMP-1r strains re-
stored parental-level protamine MICs in these constructs.
Cytoplasmic membrane fluidity. We investigated the impact
of the snoD disruption, as well as sno operon second-site
complementation, upon CM fluidity by fluorescence polariza-
FIG. 5. Plasmid map of the integrative complementation plasmid,
pJM798, showing relevant restriction sites and genes. The sno (mnh)
operon, E. coli col E1 origin of replication (ori) (pSKII), bacteriophage
L54a attachment site (attP), integrase gene (int), and the tetracycline
resistance marker (tetM) are delineated by arrows or boxes.
FIG. 6. Southern analysis of plasmid pJM798 second-site-comple-
mented strains. EcoRV-digested chromosomal DNA from ISP479R
(lane 1), ISP479R [chr::pJM798] (lane 2), TxB (lane 3), and TxB
[chr::pJM798] (lane 4) was probed with the gene encoding staphylo-
coccal glycerol ester hydrolase (geh). Upon integration into the chro-
mosome, plasmid pJM798 introduces an EcoRV site that results in two
fragments with a combined size equal to the sum of the geh EcoRV
fragment in the parental strain plus the 13 kb of pJM798.
TABLE 2. tPMP-1 and protamine susceptibility profiles
Strain
% Survival MIC of
protamine
(mg ml1)b
Profilec1 g ml1
tPMP-1a
2 g ml1
tPMP-1a
ISP479C 27  1.4*d 20  2.1* 1 S
ISP479R 84  2.1 75  3.5 8 R
ISP479R-comp 44  2.8 35  2.1 1 S
ISP479R(pJM282) 93  6.0 95  8.0 NDe R
TxB 84  6.4 82  3.5 8 R
TxB-comp 47  2.8 47  8.5 1 S
SH1000 31  5.0 21  10.0* 1 S
SH1000-98 66  6.0 59  2.0 8 R
a Mean  SD of three independent runs.
b MIC range on three independent runs.
c sensitive (S) and resistant (R) to tPMP-1 and protamine as defined in Ma-
terials and Methods.
d P  0.05 comparing the parental strain to its respective tPMP-1r mutant.
e ND, not determined.
TABLE 3. Comparative membrane fluidity profiles
Strain PI ( SD)a P value
ISP479C 0.320  0.020 0.05 vs ISP479C and
ISP479R-comp
ISP479R 0.308  0.010
ISP479R-comp 0.320  0.010
SH1000 0.325  0.025 0.05 vs SH1000
SH1000-98 0.301  0.025
a See Materials and Methods for methodologic details.
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tion spectrofluorometry. As shown in Table 3, CM fluidity was
significantly higher (i.e., lower PI values) for tPMP-1r strains
ISP479R and SH1000-98 than for their respective parental
strains (P  0.05 for all comparisons of parent versus mutant).
Similar data were observed for TxB (not shown). Furthermore,
complementation with the sno operon in ISP479R and TxB
reversed the altered CM fluidity to a more rigid state (not
shown).
Membrane potential assays. Baseline  values of the pa-
rental, transposon mutant, and transductant mutant in the
ISP479C background were similar and consistent with data
from other tPMP-1s parental strains (20) (Table 4). Although
baseline  fell modestly during late-logarithmic growth, the
parental strain reestablished a near-parental  during early
postexponential growth. In contrast, neither tPMP-1r construct
could reestablish parental-level  over this same growth pe-
riod.
Halotolerance and pH tolerance. Previous investigators pro-
posed that the mnh (sno) operon encodes a multisubunit an-
tiporter in S. aureus that only transports Na/H ions in re-
sponse to their distribution relative to the bacterial membrane
and, thus, is a secondary antiporter (15). A secondary anti-
porter, but not a complex I NADH oxidoreductase, would be
expected to substantially impact halotolerance and pH toler-
ance of the organism (15). Moreover, complex I enzymes can
be distinguished from enzymes involved in later stages of the
electron transport system (e.g., complex III enzymes) by their
effects upon growth at alkaline pH (pH 8.5) (41). Therefore,
we assessed the impact of the transposon mutation in ISP479R
and SH1000-98 on putative antiport function by comparing the
growth kinetics of these strains to their parental controls in
media containing various NaCl concentrations or buffered to
different pH levels.
All strains grew equally well at a range of NaCl concentra-
tions of 50 mM to 1.5 M (data not shown). At NaCl concen-
trations of 3 M, all strains experienced a relatively long lag
phase (8 h) before logarithmic growth ensued (data not
shown). Both tPMP-1s parental strain constructs grew better
than their mutant derivatives between 8 and 10 h of incubation
(Fig. 7). Furthermore, within a pH range between 4.5 and 8.5,
the relative growth profiles of all four strains were similar over
a 24-h incubation period (Fig. 8). Of interest, growth of
SH1000 generally exceeded that of ISP479C in both high NaCl
concentrations and under low-pH conditions, probably reflect-
ing the intact sigB stress operon in the former versus the latter
strain (16).
PMF inhibitor studies. Unlike Na/H antiporters, com-
plex I NADH oxidoreductases function to generate a proton
gradient and establish the PMF. However, these enzymes can
exhibit a secondary Na antiport activity (6). Conversely, sec-
ondary Na/H antiporters minimally contribute to genera-
tion of a proton gradient and, thus, have no effect on estab-
lishing the PMF. The PMF inhibitor CCCP caused significantly
reduced killing of both tPMP-1S parental strains ISP479C and
SH1000 over a range of tPMP-1 concentrations (Fig. 9). CCCP
impacted tPMP-1 susceptibility in a manner that was substan-
tially greater in ISP479C than in SH1000 (3- to 8.5-fold versus
a 2-fold increase in survival in the presence of tPMP-1, re-
spectively). As anticipated, CCCP did not impact tPMP-1 sus-
ceptibility profiles in tPMP-1r strains (data not shown).
Complex I enzyme inhibitor studies. To test the prediction
that disruption of a complex I enzyme results in a more
tPMP-1r phenotype, parental strains ISP479C and SH1000
were grown in the presence of the specific complex I inhibitor,
piericidin A. Similar to the impact of CCCP above, in the
presence of 4 or 8 M piericidin A, there was a significant
FIG. 7. Halotolerance of parental versus respective PMP-1r mu-
tants grown for 10 h at 37°C in NaCl-supplemented medium (3 M
NaCl). Data represent the means (SD) of three independent exper-
iments.
FIG. 8. pH tolerance of parental versus respective PMP-1r mutants
grown for 24 h at 37°C in medium adjusted to a range of pHs from 4.5
to 8.5. Data represent the mean OD600 values obtained at 24 h growth
for three independent experiments. SD bars are omitted for clarity of
figure presentation.
TABLE 4. Changes in membrane potential during growth
Time of
measurement (h)
Change in   (mV)
ISP479C ISP479R TxB
0 123 129 144
0.5 119 96 123
1 113 83 NDa
2 114 91 98
3 103 93 72
4 107 73 74
6 116 82 100
a ND, not done.
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increase in survival of both tPMP-1s parental strains in tPMP-1
compared to cells grown in the absence of this inhibitor (Fig.
10). As seen with CCCP, the extent of the piericidin A effect
was greater in strain ISP479C than SH1000. Similar to data
from CCCP exposures, piericidin A exposures caused signifi-
cant reductions in tPMP-1-induced killing of clinical strain
6850. Exposure of the tPMP-1r strains to piericidin A did not
impact their baseline susceptibility profiles to tPMP-1 (Fig.
11A). Of note, both piericidin A as well as CCCP caused a
significant reduction in tPMP-1-induced killing of clinical
strain 6850 (Fig. 11B).
DISCUSSION
Four phenotypes have been previously described as corre-
lating with reduced in vitro susceptibility to tPMPs in S. aureus:
(i) small-colony variants (SCVs), either selected by passage in
gentamicin (20) or induced by mutagenesis of the hemB or
menD locus (genes encoding components of the cytochrome
and menaquinone pathways, respectively) (20). SCVs maintain
a substantially lowered transmembrane potential than parental
strains because of defects in their electron transport chain,
especially during late log-stationary growth phases (4). Impor-
tantly, for cationic antimicrobial molecules such as aminogly-
cosides, a threshold  appears to be critical for interacting
with and transport through target microbial membranes. This
concept underlies the common finding of reduced aminogly-
coside susceptibilities in vitro for SCVs (4, 20). Of interest,
SCVs also demonstrate reduced susceptibility to tPMPs, al-
though a reduced  is not the sole determinant of the
tPMP-1r phenotype in vitro (20). (ii) Another phenotype is
variants selected following serial passages (10) of tPMP-1r S.
aureus strains in increasing concentrations of this peptide (49).
Similar to SCVs, such passage-derived tPMP-1r isolates exhib-
ited a substantially diminished  (A. S. Bayer, M. R. Yea-
man, H.-G. Sahl, D. Brar, and R. A. Proctor, Abstr. 97th Gen.
FIG. 9. Impact of CCCP treatment of tPMP-1s parental strains
upon baseline tPMP-1 susceptibility profiles. Data represent the mean
(SD) of surviving CFU after exposure to various concentrations of
tPMP-1 (0 to 2 g/ml) in the presence or absence of CCCP (100 M).
(A) Data for parental strain ISP479C. *, not significantly different from
untreated controls; **, P  0.0001 versus untreated controls; ***, P 
0.001 versus untreated controls. (B) Data for parental strain SH1000.
*, not significantly different from untreated controls; **, P  0.05
versus untreated controls. Numbers above bars in panels A and B
represent the mean fold increases in surviving CFU, comparing CCCP
exposures to no-CCCP exposures. These data represent the means of
at least two independent assays.
FIG. 10. Impact of piericidin A treatment of tPMP-1s parental
strains upon baseline tPMP-1 susceptibility profiles. Data represent
the mean (SD) of surviving CFU after tPMP-1 exposures (1 g/ml)
in the presence or absence of piericidin A (0, 4, or 8 M). (A) Data for
parental strain ISP479; (B) data for parental strain SH1000. Numbers
above bars represent the mean fold increase in surviving CFU com-
paring piericidin A exposures to no-exposure controls. These data
represent the means of at least two independent assays. *, not signif-
icantly different from untreated controls; **, P 0.05 versus untreated
controls.
218 BAYER ET AL. J. BACTERIOL.
Meet. Am. Soc. Microbiol., abstr. A-106, p. 19, 1997). (iii)
Strains with relative increases in cell surface positive charge
are a third phenotype. Peschel et al. have recently observed
that the CM and cell walls of S. aureus contain a high propor-
tion of positively charged phospholipids and teichoic acids,
respectively, rendering such strains relatively resistant to kill-
ing by a broad range of cationic antimicrobial peptides, includ-
ing tPMP-1 (38, 39). For the CM and cell walls, lysinylation of
phosphotidyl-glycerol (38) and D-alanylation of teichoic acid
(39), respectively, appear to be responsible for this phenotype.
The proposed mechanism by which such positively charged
surface envelope species are associated with reduced suscep-
tibility to cationic peptides is via a charge-based surface repul-
sion (39). Finally, (iv) strains carrying plasmid determinants for
cation export are the fourth phenotype. Staphylococci carrying
plasmids (e.g., pSK1) encoding PMF-dependent, cation export
pumps of the major facilitator superfamily (e.g., QacA) also
exhibit reduced susceptibility to tPMP-1 in vitro, compared to
isogenic plasmid-cured or qacA mutant constructs (26). The
mechanism by which qacA expression confers reduced suscep-
tibility to tPMPs remains unclear, although we have recently
shown that tPMP-1 export does not play a role. (L. I. Kupfer-
wasser et al., Abstr. 40th Intersci. Conf. Antimicrob. Agents
Chemother., abstr. 2288, 2000).
Despite distinct derivation strategies, strains with reduced
susceptibilities to tPMP-1 (including the mutants in the current
study) share selected phenotypic characteristics. We have pre-
viously shown that tPMP-1r strains exhibit increased mem-
brane fluidity compared to their respective parental strains (5).
The current study extends this observation, in that all the
tPMP-1r transposon mutants demonstrated increased mem-
brane fluidity. Also, similar to SCVs and tPMP-1r strains cre-
ated by serial passage, the current transposon mutant strains
all exhibited a reduced  compared to their respective pa-
rental strains. Thus, both the parental strain and tPMP-1r
constructs were able to maintain their initial  due to the
rapid consumption of glucose and excretion of lactic acid in a
minimal medium. Ostensibly, lactic acid is then taken up by
these cells under microaerophilic conditions and then com-
pletely oxidized (4, 42). However, strains with impaired elec-
tron transport (e.g., SCVs and complex I mutants) cannot
subsequently maintain their  (4).
Substantiating these concepts, preliminary data from
tPMP-1r strains (compared to their respective parental strains)
have two common CM features: (i) shorter fatty acid acyl chain
length and (ii) increases in anteiso:iso branched chain fatty
acid ratios (K. Mukhopadhyay et al., Abstr. 105th Gen. Meet.
Am. Soc. Microbiol., abstr. A-002, p. 1, 2005). These latter
parameters have been correlated with increased membrane
fluidity in B. subtilis, particularly as part of the organism’s
response to cold shock (19). Of importance, increased mem-
brane fluidity in biologic membranes has also been associated
with excess proton leak, which itself contributes to a loss of 
(7). In addition, extremes of CM fluidity or rigidity are likely to
impact the interactions of antimicrobial peptides with the tar-
get membrane (28). It should be emphasized that relatively
small changes in CM characteristics (such as fluidity) have a
major impact upon interactions with antimicrobial peptides
(40).
The availability of a series of isogenic tPMP-1r strains pro-
vided a unique opportunity to further characterize the genetic
basis for the tPMP-1r phenotype. Sequence analysis of chro-
mosomal DNA flanking the ends of the transposon in tPMP-1r
strains revealed that the transposon mutation resides within a
gene encoding a member of the NADH-ubiquinone/plastoqui-
none (complex I) protein family. Complex I is a large, multi-
subunit respiratory chain enzyme that catalyzes the oxidation
of NADH to NAD, the reduction of quinone to quinol, and
the transmembrane transfer of H. Thus, this enzyme is crit-
ical in establishing the proton gradient and the PMF, especially
under microaerophilic conditions and/or when linked to nitrate
reductase. Three genes encoding complex I subunits in Esch-
FIG. 11. (A) Demonstration of the impact of piericidin A treat-
ment upon baseline tPMP-1 susceptibility profiles in two tPMP-1r
strains. Numbers above bars represent the mean fold increases in
surviving CFU comparing piericidin exposures to no-exposure con-
trols. Data represent the mean (SD) surviving CFU after tPMP-1
exposures (1 g/ml) in the presence or absence of inhibitor. There
were no significant changes in the presence of piericidin A. (B) Dem-
onstration of the impact of two PMF inhibitors upon the tPMP-1
susceptibility profiles for clinical strain 6850. Numbers above bars
represent the mean fold increases in surviving CFU comparing inhib-
itor exposures to no-exposure controls. Data represent the mean
(SD) of surviving CFU after tPMP-1 exposures (1 g/ml) in the
presence or absence of piericidin A (8 M) or CCCP (100 M). These
data represent the means of at least two independent assays. *, P 
0.001; **, P  0.0001.
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erichia coli, nuoL, nuoM, and nuoN, have homology with es-
tablished Na (K)/H antiporters. From an evolutionary per-
spective, it has been postulated that these subunits were
ancestral antiport modules recruited to complex I (30, 31).
Complex I-like antiporters have been identified in genome
databases from diverse organisms and have been shown to
function in the transmembrane exchange of Na, K, cholate,
and H (3, 14, 17, 22, 23, 30, 41).
Staphylococcal snoD, like mrpD of Bacillus subtilis, resides in
a seven-gene operon (17). These seven genes encode homol-
ogous proteins, and the overall architecture of the two operons
is identical (17). In addition to a putative Na and cholate
efflux pump encoded by mrpC and a solute-dependent pump
encoded by mrpF, the products of the mrp operon appear to be
required components of a redox-energized transporter in B.
subtilis (18). The genes immediately upstream and downstream
of the sno operon in S. aureus (SA0814 and SA0806, respec-
tively) differ from those flanking mrp in B. subtilis. SA0814 is
predicted to encode kinase-associated protein B, a B. subtilis
kinB homologue, while SA0806 encodes a pyridine nucleotide-
disulfide oxidoreductase family member (pfam 00070) with
homology to a flavoprotein that is involved in K transport
(GenBank accession no. 53736091). In B. subtilis, mpr is
flanked by purT and ybfJ (a gene of unknown function that
lacks homology with SA0806). The divergence in the sequences
flanking the two loci suggest that disruption of sno operon
function (rather than that of adjacent genes) is sufficient to
confer the observed phenotypes associated with the tPMP-1r
strains.
To verify the phenotypic consequences of the sno mutation,
a wild-type copy of sno was reintroduced into the chromosome
of several mutant constructs. This resulted in full restoration of
parental-level protamine susceptibility to mutant strains, but
only partial restoration of the tPMP-1s phenotype. The lack of
full reconstitution of tPMP-1 susceptibility upon complemen-
tation is not unexpected and has been seen in other investiga-
tions of genetic loci involved in cationic peptide resistance (38,
39). Such lack of full phenotypic complementation has been
variably ascribed to (i) plasmid copy number, (ii) plasmid sta-
bility, (iii) chromosomal integration of wild-type genes into a
“nonnative” genetic context (i.e., into the lipase locus), or (iv)
gene dosage effects from two or more copies of a gene of
interest in the restored operon. While the latter two explana-
tions apply to the current study, complementation of the sno
operon may also be affected by the interference of products
from a second sno-like gene identified in the genome of S.
aureus N315 (SA0579 through SA0585). SnoD may encode the
only gene product affected by the transposon mutation. How-
ever, we recognize that the expression of genes both upstream
and downstream of snoD may have altered expression second-
ary to transposon disruption. Presently, we are examining the
transcriptional capacity of the sno operon and creating a series
of nonpolar deletion mutations in each of its seven genes to
adjudicate these possibilities.
As noted before, the sno (mnh) operon was previously as-
cribed Na/H antiporter function (15). However, our current
data are more consistent with sno encoding a redox-energized
complex involved in PMF maintenance, rather than a second-
ary Na/H antiporter. In their original description of the mnh
(sno) operon, Hiramatsu et al. (15) showed that an E. coli
strain devoid of its major native Na/H antiporters and which
harbored a plasmid containing the sno operon was better able
to survive an NaCl challenge. However, these data are also
compatible with sno encoding a primary complex I-like enzyme
system that supports Na transport, a possibility not addressed
in the previous publication. In addition, these same investiga-
tors found that sno-encoded Na transport was susceptible to
the PMF inhibitor CCCP. While prototypical secondary
Na/H antiporters are sensitive to H concentrations and
therefore are PMF dependent, these data also support sno
encoding a primary antiporter (e.g., energy providing, reaction
coupled) (3, 24). Moreover, in our investigations, tPMP-1r
constructs only exhibited a reduction in growth at high levels of
NaCl, a finding also consistent with sno encoding a primary,
FIG. 12. Hypothetical model of the role of SnoA-G in electron transport in S. aureus. Depicted are the CM-associated components of a
hypothetical electron transport chain: menaquinone (MK), the ATP synthase (F0 F1 ATPase), an aa3-type cytochrome (aa3), quinol oxidase
(QoxA-D), the staphylococcal nuo-like orthologue complex (SnoA-G) coupled to an unidentified protein or proteins with NADH oxidase activity,
a bd-type cytochrome, and nitrate reductase (NR). Reactions catalyzed by constituents of the hypothetical electron transport chain are shown in
association with proteins or protein complexes. The thick arrows illustrate the flow of hydrogen ions (H; dashed arrow). The aa3-type cytochromes
are used in aerobic metabolism and are most closely linked to QoxA-D, an aerobic NADH oxidase. The bd-type cytochromes are used in
microaerophilic and anaerobic metabolism and are linked to SnoA-G. Reduced susceptibility of S. aureus to tPMP-1 is predicted to be due to (i)
the reduction in  due to the loss of H translocation from the inside to the outside of the bacterium, from decreased electron flow to cytochrome
bd, and (ii) an increase in diffusion of H from the outside to the inside of the bacterium caused by disordering (increased fluidity; dashed line)
of the cytoplasmic membrane due to a shift from longer to shorter fatty acids and an increase in branched fatty acids.
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not a secondary, Na/H antiporter. Similarly, there were no
differences in the growth kinetics of the mutant strains com-
pared to the parental strains when grown under alkaline con-
ditions. Secondary Na/H antiporters would be expected to
maximally function at alkaline pH. Finally, the tPMP-1r phe-
notype could be mimicked in both tPMP-1s parental strains by
blocking the PMF with CCCP as well as by using the complex
I inhibitor piericidin A.
Collectively, the above data strongly suggest that the re-
duced susceptibility to tPMP-1 and protamine in our transpo-
son and transductant mutants involves disruption of a complex
I-like enzyme locus. Moreover, these findings further
strengthen our prior data, which emphasize the pivotal rela-
tionship between maintenance of a threshold  and optimal
in vitro killing of S. aureus by tPMP-1 (20, 21, 48).
The electron transport systems of S. aureus as of yet are
poorly defined. However, data available from the complete
genomic sequences of this organism and from the current study
suggest there are at least two distinct enzyme complexes that
oxidize NADH and form part of the electron transport chain,
QoxA-D and SnoA-G. Qox is a quinone oxidase that functions
most efficiently under aerobic conditions (53). This gene is
intact in snoD mutants; thus, these strains can transfer elec-
trons to molecular oxygen using a mechanism that depends
upon Qox complexes. However, the Sno complex becomes the
predominant NADH oxidoreductase under microaerophilic
conditions, when substrates and/or oxygen become limiting and
when nitrate is used as the terminal electron acceptor. Both the
enzymes above can generate a PMF via creation of the proton
gradient, with the activity and efficiency of each system being
dependent on substrate and oxygen availabilities. Our  data
support a key role for snoA-G in the generation of a PMF;
however, further studies will be needed to delineate the net
role of the Sno complex in the oxidation of NADH and elec-
tron transport. In Fig. 12 we present a hypothetical model of
the role of SnoA-G within the electron transport chain of S.
aureus and comment upon the impact of SnoA-G on tPMP
susceptibilities.
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